Literature DB >> 22727799

Prevalence and clinical characteristics of peripheral arterial disease in the study population Hermex.

Francisco J Félix-Redondo1, Daniel Fernández-Bergés, María Grau, José M Baena-Diez, José M Mostaza, Joan Vila.   

Abstract

INTRODUCTION AND
OBJECTIVES: To estimate the prevalence of peripheral arterial disease as measured on ankle-brachial index and evaluate the associated risk, clinical, and diagnostic factors.
METHODS: Cross-sectional study conducted in a random population-based sample of 2833 individuals aged 25 to 79 years from Don Benito health area (Badajoz). Peripheral arterial disease was considered for ankle-brachial index<0.90. To identify symptomatic disease we used the Edinburgh questionnaire. The current screening recommendations, changes to other categories of estimated coronary risk associated with index measurements, and the association with risk factors were assessed.
RESULTS: The prevalence of peripheral arterial disease was 3.7% (95% confidence interval, 3.0%-4.5%), 5.0% (3.9%-6.3%) in men and 2.6% (1.8%-3.5%) in women (P=.001). The cumulative prevalence in those aged 50, 60 and 70 years were 6.2%, 9.1%, and 13.1% respectively. The disease was symptomatic in 13.3% (6.8%-19.8%) of cases and 29.6% of asymptomatic patients were not detected as recommended for high-risk groups. The use of ankle-brachial index increased the number of individuals with high coronary risk by 32.7%. Peripheral arterial disease was positively associated with age, smoking, hypercholesterolemia, sedentary lifestyle, microalbuminuria and history of cardiovascular disease, and negatively with alcohol consumption.
CONCLUSIONS: The use of ankle-brachial index for peripheral arterial disease diagnosis is advisable because of the low prevalence of symptomatic cases and the associated change in estimated coronary risk. Screening groups should be adapted to the Spanish population. Smoking and hypercholesterolemia are major associated risk factors.
Copyright © 2012 Sociedad Española de Cardiología. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22727799     DOI: 10.1016/j.recesp.2012.03.008

Source DB:  PubMed          Journal:  Rev Esp Cardiol (Engl Ed)        ISSN: 1885-5857


  12 in total

1.  Cardiovascular risk factors, lifestyle, and social determinants: a cross-sectional population study.

Authors:  Luis Palomo; Francisco-Javier Félix-Redondo; Luis Lozano-Mera; José-Fernando Pérez-Castán; Daniel Fernández-Berges; Francisco Buitrago
Journal:  Br J Gen Pract       Date:  2014-10       Impact factor: 5.386

Review 2.  Peripheral arterial disease, type 2 diabetes and postprandial lipidaemia: Is there a link?

Authors:  Pedro Valdivielso; José Ramírez-Bollero; Carmen Pérez-López
Journal:  World J Diabetes       Date:  2014-10-15

3.  Cholesterol and cardiovascular disease in the elderly. Facts and gaps.

Authors:  Francisco J Félix-Redondo; Maria Grau; Daniel Fernández-Bergés
Journal:  Aging Dis       Date:  2013-03-01       Impact factor: 6.745

4.  Incidence of peripheral arterial disease in the ARTPER population cohort after 5 years of follow-up.

Authors:  Ma Teresa Alzamora; Rosa Forés; Guillem Pera; José Miguel Baena-Díez; Antonio Heras; Marta Sorribes; Marta Valverde; Laura Muñoz; Xavier Mundet; Pere Torán
Journal:  BMC Cardiovasc Disord       Date:  2016-01-12       Impact factor: 2.298

5.  Time trends in peripheral artery disease incidence, prevalence and secondary preventive therapy: a cohort study in The Health Improvement Network in the UK.

Authors:  Lucía Cea-Soriano; F Gerry R Fowkes; Saga Johansson; Alaster M Allum; Luis Alberto García Rodriguez
Journal:  BMJ Open       Date:  2018-01-21       Impact factor: 2.692

6.  Safety of cilostazol in peripheral artery disease: a cohort from a primary healthcare electronic database.

Authors:  Jordi Real; M Catalina Serna; Maria Giner-Soriano; Rosa Forés; Guillem Pera; Esther Ribes; Maite Alzamora; Josep Ramon Marsal; Antonio Heras; Rosa Morros
Journal:  BMC Cardiovasc Disord       Date:  2018-05-08       Impact factor: 2.298

7.  Limb Revascularization of Peripheral Artery Disease in the Developing Countries: Earliest 1-Year Experience from Northwestern Nigeria.

Authors:  Anas Ismail; Abulkadir M Tabari; Kabiru Isyaku; Nafiu Ahmed
Journal:  Niger J Surg       Date:  2019 Jan-Jun

Review 8.  Prevalence, Treatment, and Control of Hypercholesterolemia in High Cardiovascular Risk Patients: Evidences from a Systematic Literature Review in Spain.

Authors:  Alex de la Sierra; Xavier Pintó; Carlos Guijarro; José López Miranda; Daniel Callejo; Jesús Cuervo; Rudi Subirà; Marta Rubio
Journal:  Adv Ther       Date:  2015-10-26       Impact factor: 3.845

9.  Ankle-brachial index and the incidence of cardiovascular events in the Mediterranean low cardiovascular risk population ARTPER cohort.

Authors:  Maria Teresa Alzamora; Rosa Forés; Guillem Pera; Pere Torán; Antonio Heras; Marta Sorribes; Jose Miguel Baena-Diez; Magalí Urrea; Judit Alegre; María Viozquez; Carme Vela
Journal:  BMC Cardiovasc Disord       Date:  2013-12-17       Impact factor: 2.298

10.  Prevalence of peripheral artery disease (PAD) and factors associated: An epidemiological analysis from the population-based Screening PRE-diabetes and type 2 DIAbetes (SPREDIA-2) study.

Authors:  V Cornejo Del Río; J Mostaza; C Lahoz; V Sánchez-Arroyo; C Sabín; S López; P Patrón; P Fernández-García; B Fernández-Puntero; D Vicent; L Montesano-Sánchez; F García-Iglesias; T González-Alegre; E Estirado; F Laguna; C de Burgos-Lunar; P Gómez-Campelo; J C Abanades-Herranz; J M de Miguel-Yanes; M A Salinero-Fort
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.